High-risk prostate cancer
Clinical trials for High-risk prostate cancer explained in plain language.
Never miss a new study
Get alerted when new High-risk prostate cancer trials appear
Sign up with your email to follow new studies for High-risk prostate cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a shorter hormone therapy course be just as effective for High-Risk prostate cancer?
Disease control Not yet recruitingThis phase III trial is investigating whether a shorter course of hormone therapy (12 months) is as effective as the standard longer course (24 months) for certain men with high-risk prostate cancer. The study uses imaging and tumor tests to identify patients who might benefit fr…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase 3 • Sponsor: Dr. Tamim Niazi • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New cocktail aims to wipe out prostate cancer before surgery
Disease control Not yet recruitingThis early-phase trial tests whether adding two drugs (darolutamide and homoharringtonine) to standard chemo and hormone therapy can more thoroughly clear high-risk prostate cancer before surgery. About 94 men will receive the combo for 7 weeks, then have their prostate removed t…
Matched conditions: HIGH-RISK PROSTATE CANCER
Early phase 1 • Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Heart drug shows promise in prostate cancer fight
Disease control Not yet recruitingThis study tests whether adding the heart medication propranolol to standard hormone therapy before prostate removal can improve outcomes for high-risk prostate cancer patients. About 30 men will receive the combination treatment for several weeks before surgery. The goal is to s…
Matched conditions: HIGH-RISK PROSTATE CANCER
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC